Neonatal examination and screening trial (NEST): a randomised, controlled, switchback trial of alternative policies for low risk infants

BMJ. 1999 Mar 6;318(7184):627-31. doi: 10.1136/bmj.318.7184.627.

Abstract

Objective: To evaluate the effectiveness of one rather than two hospital neonatal examinations in detection of abnormalities.

Design: Randomised controlled switchback trial.

Setting: Postnatal wards in a teaching hospital in north east Scotland.

Participants: All infants delivered at the hospital between March 1993 and February 1995.

Intervention: A policy of one neonatal screening examination compared with a policy of two.

Main outcome measures: Congenital conditions diagnosed in hospital; results of community health assessments at 8 weeks and 8 months; outpatient referrals; inpatient admissions; use of general practioner services; focused analysis of outcomes for suspected hip and heart abnormalities.

Results: 4835 babies were allocated to receive one screening examination (one screen policy) and 4877 to receive two (two screen policy). More congenital conditions were suspected at discharge among babies examined twice (9.9 v 8.3 diagnoses per 100 babies; 95% confidence interval for difference 0.3 to 2.7). There was no overall significant difference between the groups in use of community, outpatient, or inpatient resources or in health care received. Although more babies who were examined twice attended orthopaedic outpatient clinics (340 (7%) v 289 (6%)), particularly for suspected congenital dislocation of the hip (176 (3.6/100 babies) v 137 (2.8/100 babies); difference -0.8; -1.5 to 0.1), there was no significant difference in the number of babies who required active management (12 (0.2%) v 15 (0.3%)).

Conclusions: Despite more suspected abnormalities, there was no evidence of net health gain from a policy of two hospital neonatal examinations. Adoption of a single examination policy would save resources both during the postnatal hospital stay and through fewer outpatient consultations.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ambulatory Care
  • Congenital Abnormalities / diagnosis*
  • Cross-Over Studies
  • Female
  • Heart Defects, Congenital / diagnosis
  • Hip / abnormalities
  • Hospitalization
  • Humans
  • Infant, Newborn
  • Male
  • Neonatal Screening / organization & administration*
  • Organizational Policy
  • Perinatal Care / organization & administration
  • Risk Factors